Neurology · 2006 · 75 citations · 4 references
MedicineNeurologyNeuroscienceDementiaNeuropharmacologyPsychopharmacologyBrain ImagingCognitive ImpairmentDementia BiomarkersDementia TreatmentMagnetic Resonance SpectroscopyNeurocognitive Assessment1D Proton Nuclear Magnetic Resonance SpectroscopyMagnetic ResonanceNuclear Magnetic Resonance SpectroscopyResponse PredictionResponse Prediction ModelsTreatment Outcome MeasurementTreatment Outcome MonitoringTreatment Response Biomarkers
In this proton magnetic resonance spectroscopy ((1)H-MRS) study, the authors correlated cognitive improvement after 3 months of treatment with donepezil with changes of N-acetylaspartate (NAA) level and NAA/Creatine (Cr) ratio in the medial temporal and parietal lobe of 17 patients with Alzheimer disease. Treatment response was associated with an increase of NAA and NAA/Cr in the parietal lobe. Low baseline NAA/Cr in the parietal lobe predicted positive treatment outcome.
4